Stuttgart - Delayed Quote • EUR
AnaptysBio, Inc. (AN6.SG)
At close: April 26 at 5:47 PM GMT+2
Key Executives
Key Executives Information Not Available
AnaptysBio, Inc.
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
AnaptysBio, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
May 09, 2024 - May 13, 2024
AnaptysBio, Inc. Earnings Call
Related Tickers
TARA Protara Therapeutics, Inc.
2.9250
-4.10%
XNCR Xencor, Inc.
19.98
+3.90%
MORF Morphic Holding, Inc.
28.07
+0.32%
RVMD Revolution Medicines, Inc.
35.96
+1.78%
GLPG Galapagos NV
28.76
+0.45%
ANAB AnaptysBio, Inc.
21.00
+11.29%
PRTA Prothena Corporation plc
20.87
+1.51%
RLFTF Relief Therapeutics Holding SA
1.4500
0.00%
ARVN Arvinas, Inc.
32.37
+2.44%
QNRX Quoin Pharmaceuticals, Ltd.
0.6375
+1.21%